Top Markets
Coin of the day
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
주식 순위 #39891
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
주가
$0.80961743
마지막 동기화: 2026-08-13
시가총액
$305.68K
변동 (1일)
0.00%
변동 (1년)
-5.76%
국가
GB
거래 Arecor Therapeutics plc (AREC)

카테고리

Arecor Therapeutics plc (AREC)의 EPS
2026 기준 EPS TTM: 0
Arecor Therapeutics plc의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Arecor Therapeutics plc의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS